Ishita Drugs & Industries Ltd
₹77.80▲ +5.10 (+7.02%)
ISHITADR·BSE·Healthcare
Market Cap
19.99 Cr
PE Ratio
29.92
Volume
111
Day High - Low
83.50 - 72.70
52W High-Low
90.85 - 66.00
₹77.80▲ +5.10 (+7.02%)
Market Cap19.99 Cr
PE Ratio29.92
Volume111
Day High - Low83.50 - 72.70
52W High-Low90.85 - 66.00
Ishita Drugs & Industries Ltd (ISHITADR): company summary
The company's annual revenue fell 2.3% to ₹15 crore, while annual net profit dropped 10.3% to ₹1 crore.
Ishita Drugs & Industries Ltd (ISHITADR) is a micro-cap Healthcare company valued at ₹20 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Ishita Drugs & Industries Ltd last traded at ₹77.8, sharply up 7.02% on the day.
- Financial performance
- The company's annual revenue fell 2.3% to ₹15 crore, while annual net profit dropped 10.3% to ₹1 crore. The latest quarter saw revenue fall 41.7% year-on-year to ₹3 crore, and net profit remained at ₹0 crore, continuing a trend of zero profit in the last four quarters.
- Valuation multiples
- The stock trades at 29.9 times earnings, broadly in line with the Healthcare median of 32.0, 1.91 times book value.
- Things to watch
- The company's net profit margin narrowed 0.5 percentage points to 5.3%, and net profit fell 10.3% year-on-year. The latest quarter's net profit remained at zero, indicating ongoing challenges in generating earnings. The stock is 20.0% below its 52-week high, reflecting a lack of recent price momentum.
- Where it stands
- Ishita Drugs & Industries Ltd ended the latest quarter with zero net profit, continuing a pattern of no earnings for the last four quarters. The stock is 20.0% below its 52-week high, and the net profit margin has declined, signaling pressure on profitability.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
3.6/10
Poor
Fair Value
Sign in to see
ROE
6.73%
Weak
P/E
29.92x
Fair
Debt / Equity
0.01
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Poor
Price performance
Day₹72.70
₹83.50
52W₹66.00
₹90.85
DocStoX take
Supported by risk (7.4), but held back by growth (1.2).
DocStoX score
Low confidence3.6
/10
Poor
Quality
Modest
ROE 6.7%
Valuation
Expensive
P/E 29.9×
Growth
Flat
Revenue +1.0% 5Y CAGR
Risk
Moderate
D/E 0.01
Momentum
Soft
47% of 52-week range
At a glance
Market Cap
₹20 Cr
52W High / Low
₹91 / ₹66
Dividend Yield
0.00%
Promoter Holding
50.04%
EPS (TTM)
₹2.60
Book Value
₹38.69
Key highlights
- Low leverage — D/E 0.01
- Profitable in all of the last 5 years
- Profit shrinking 1% a year
- Valuation is weak (2.3/10)
2 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Ishita Drugs & Industries Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Ishita Drugs & Industries Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LLAURUS LABS LIMITEDZYDUS LIFESCIENCES LTDAPOLLO HOSPITALS ENTER. LCIPLA LTDDR. REDDY S LABORATORIESAUROBINDO PHARMA LTDMANKIND PHARMA LIMITEDLUPIN LIMITEDMANIPAL HEALTH ENTERPRI L
Compare Ishita Drugs & Industries Ltd with peers
Ishita Drugs & Industries Ltd vs SUN PHARMACEUTICAL IND LIshita Drugs & Industries Ltd vs DIVI S LABORATORIES LTDIshita Drugs & Industries Ltd vs TORRENT PHARMACEUTICALS LIshita Drugs & Industries Ltd vs LAURUS LABS LIMITEDIshita Drugs & Industries Ltd vs ZYDUS LIFESCIENCES LTDIshita Drugs & Industries Ltd vs APOLLO HOSPITALS ENTER. L
Related tools & concepts
Value Ishita Drugs & Industries Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing